Association of hemoglobin variability and mortality among contemporary incident hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 3, Issue 6, 2008, Pages 1733-1740

  Brunelli, Steven M ^a   Lynch, Katherine E ^a   Ankers, Elizabeth D ^b   Joffe, Marshall M ^a   Yang, Wei ^a   Thadhani, Ravi I ^b   Feldman, Harold I ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

AGED; ANEMIA; ARTICLE; CHRONIC DISEASE; COHORT ANALYSIS; FEMALE; HUMAN; INCIDENCE; KAPLAN MEIER METHOD; KIDNEY DISEASE; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME;

AGED; ANEMIA; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HEMOGLOBINS; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 58149352646     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02390508     Document Type: Article

References (22)

1. U.S. Renal Data System: USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007; http://www.usrds.org, Accessed October 25, 2007
2. Pisoni RL, Bragg-Gresham JL, Young EW, Akizawa T, Asano Y, Locatelli F, Commer J, Cruz JM, Kerr PG, Mendelssohn DC, Held PJ, Port FK: Anemia management and outcomes from 12 countries in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44: 94-111, 2004
3. Plantinga LC, Fink NE, Jaar BG, Huang I, Wu AW, Meyer KB, Powe NR: Relation between level of changes of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res 16: 755-765, 2007
4. Moreno F, Sanz-Guajardo D, López-Gómez JM, Jofre R, Valderrábano F: Increasing the hematocrit has a beneficial effect on quality of life and is safe in selected hemodialysis patients. J Am Soc Nephrol 11: 335-342, 2000
5. McMahon LP, McKenna MJ, Sangkabutra T, Mason K, Sostaric S, Skinner SL, Burge C, Murphy B, Crankshaw D: Physical performance and associated electrolyte changes after haemoglobin normalization: a comparative study in haemodialysis patients. Nephrol Dial Transplant 14: 1182-1187, 1999
6. Robinson BM, Joffe MM, Berns JS, Pisoni RL, Port FK, Feldman HI: Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time. Kidney Int 68: 2323-2330, 2005
7. Portolés J, López-Gómez JM, Aljama P: A prospective multicenter study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study. Nephrol Dial Transplant 22: 500-507, 2007
8. Rao M, Pereira BJ: Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease. Kidney Int 68: 1432-1438, 2005
9. Ma JZ, Ebben J, Xia H, Collins AJ: Hematocrit level and associated mortality in hemodialysis patients. J Am Soc Nephrol 10: 610-619, 1999
10. Li S, Collins AJ: Association of hematocrit value with cardiovascular morbidity and mortality in incident hemodialysis patients. Kidney Int 65: 626-633, 2004
11. Spiegel DM: Anemia management in chronic kidney disease: what have we learned after 17 years? Semin Dial 19: 269-272, 2006
12. National Kidney Foundation: NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2007, http://www.kidney.org/ professionals/kdoqi/index.com, Accessed October 25, 2007
13. Fishbane S, Berns JS: Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin. Kidney Int 68: 1337-1343, 2005
14. Fishbane S, Berns JS: Evidence and implications of haemoglobin cycling in anemia management. Nephrol Dial Transplant 22: 2129-2132, 2007
15. Berns JS, Elzein H, Lynn RI, Fishbane S, Meisels IS, DeOreo PB: Hemoglobin variability in epoetin-treated hemodialysis patients. Kidney Int 64: 1514-1521, 2003
16. West RM, Harris K, Gilthorpe MS, Tolman C, Will EJ: A description of the variability of patient responses in the control of renal anemia: functional data analysis applied to a randomized controlled clinical trial in hemodialysis patients. J Am Soc Nephrol 18: 2371-2376, 2007
17. Ebben JP, Gibertson DT, Foley RN, Collins AJ: Hemoglobin level variability: associations with comorbidity, intercurrent events, and hospitalizations. Clin J Am Soc Nephrol 1: 1205-1210, 2006
18. Yang W, Israni RK, Brunelli SM, Joffe MM, Fishbane S, Feldman HI: Hemoglobin variability and mortality in ESRD. J Am Soc Nephrol 18: 3164-3170, 2007
19. Gibertson DT, Ebben JB, Bradbury B, Dunning SC, Collins AJ: The effect of hemoglobin (Hb) variability and trends on mortality. J Am Soc Nephrol 17: 582A, 2006
20. Thadhani R, Tonelli M: Cohort studies: marching forward. Clin J Am Soc Nephrol 1: 1117-1123, 2006
21. Gilbertson DT, Ebben JP, Foley RN, Weinhardl ED, Bradburry BD, Collins AJ: Hemoglbin level variability: associations with mortality. Clin J Am Soc Nephrol 3: 133-138, 2008
22. Brunelli SM, Joffe MM, Israni RK, Yang W, Fishbane S, Berns JS, Feldman HI: History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients. Clin J Am Soc Nephrol 3: 777-782, 2008